1. Home
  2. Labeler Index
  3. Remedyrepack Inc.
  4. 70518-0122
  5. Product Images: Duloxetine Delayed-release

Product Images Duloxetine Delayed-release

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. Remedy_Label - Remedy Label
  2. Chemical Structure - duloxetine 01
  3. Figure 1 - duloxetine 02
  4. Figure 2 - duloxetine 03
  5. Figure 3 - duloxetine 04
  6. Figure 4 - duloxetine 05
  7. Figure 5 - duloxetine 06
  8. Figure 6 - duloxetine 07
  9. Figure 7 - duloxetine 08
  10. Figure 8 - duloxetine 09
  11. Figure 9 - duloxetine 10
  12. Figure 10 - duloxetine 11

Product Label Images

The following 12 images provide visual information about the product associated with Duloxetine Delayed-release NDC 70518-0122 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

This is information regarding a medication called DULoxetine in the form of delayed-release 60 mg capsules. The prescription contains 90 capsules and is to be used as directed. The medication is manufactured by Breckenridge in Boca Raton, FL. It should be stored at a temperature between 20-25°C (58-77°F). Make sure to keep this medication out of reach of children. For further details, refer to the package insert.*

Chemical Structure - duloxetine 01

Chemical Structure - duloxetine 01

Figure 1 - duloxetine 02

Figure 1 - duloxetine 02

This is a chart showing the proportion of patients experiencing a relapse over time. It compares the relapse rates between a placebo group and a group taking a drug named Dulcolax (dolayocrakasa capsiles). The chart suggests that the group taking the drug has a lower relapse rate compared to the placebo group.*

Figure 2 - duloxetine 03

Figure 2 - duloxetine 03

This text provides information on the proportion of patients with relapse over a specific timeline for a study comparing a placebo with Duloxetine delayed-release capsules. The data shows the number of patients experiencing relapse at different time points in the study.*

Figure 3 - duloxetine 04

Figure 3 - duloxetine 04

Figure 4 - duloxetine 05

Figure 4 - duloxetine 05

Figure 5 - duloxetine 06

Figure 5 - duloxetine 06

Figure 6 - duloxetine 07

Figure 6 - duloxetine 07

Not available.*

Figure 7 - duloxetine 08

Figure 7 - duloxetine 08

Figure 8 - duloxetine 09

Figure 8 - duloxetine 09

Figure 9 - duloxetine 10

Figure 9 - duloxetine 10

Percentage of Patients Improved. Percent Improvement in Pain from Baseline (BOCF).*

Figure 10 - duloxetine 11

Figure 10 - duloxetine 11

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.